AU2003234416A1 - Use of completely linear short chain alpha-glucans as a pharmaceutical excipient - Google Patents

Use of completely linear short chain alpha-glucans as a pharmaceutical excipient

Info

Publication number
AU2003234416A1
AU2003234416A1 AU2003234416A AU2003234416A AU2003234416A1 AU 2003234416 A1 AU2003234416 A1 AU 2003234416A1 AU 2003234416 A AU2003234416 A AU 2003234416A AU 2003234416 A AU2003234416 A AU 2003234416A AU 2003234416 A1 AU2003234416 A1 AU 2003234416A1
Authority
AU
Australia
Prior art keywords
glucans
short chain
pharmaceutical excipient
chain alpha
completely linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234416A
Other languages
English (en)
Inventor
Sibu Chakrabarti
Xiaoyuan Cui
Yong-Cheng Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Starch and Chemical Investment Holding Corp
Original Assignee
National Starch and Chemical Investment Holding Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Starch and Chemical Investment Holding Corp filed Critical National Starch and Chemical Investment Holding Corp
Publication of AU2003234416A1 publication Critical patent/AU2003234416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2003234416A 2002-05-14 2003-05-13 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient Abandoned AU2003234416A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38050802P 2002-05-14 2002-05-14
US60/380,508 2002-05-14
US10/298,813 2002-11-18
US10/298,813 US20030215499A1 (en) 2002-05-14 2002-11-18 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient
PCT/US2003/014944 WO2003097017A1 (en) 2002-05-14 2003-05-13 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient

Publications (1)

Publication Number Publication Date
AU2003234416A1 true AU2003234416A1 (en) 2003-12-02

Family

ID=29423266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234416A Abandoned AU2003234416A1 (en) 2002-05-14 2003-05-13 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient

Country Status (5)

Country Link
US (1) US20030215499A1 (https=)
EP (1) EP1503738A1 (https=)
JP (1) JP2005530777A (https=)
AU (1) AU2003234416A1 (https=)
WO (1) WO2003097017A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
US7189288B2 (en) * 2004-10-08 2007-03-13 Tate & Lyle Ingredients Americas, Inc. Enzyme-resistant starch and method for its production
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
US7276126B2 (en) * 2005-06-03 2007-10-02 Tate And Lyle Ingredients Americas, Inc. Production of enzyme-resistant starch by extrusion
US7674897B2 (en) * 2005-09-09 2010-03-09 Tate & Lyle Ingredients Americas, Inc. Production of crystalline short chain amylose
US7608436B2 (en) * 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) * 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
FR2902929B1 (fr) * 2006-06-26 2009-05-22 Commissariat Energie Atomique Dispersion aqueuse a base d'amidon et d'oxyde mixte de lithium et de titane, pour une electrode d'accumulateur au lithium.
TWI727188B (zh) * 2018-07-19 2021-05-11 大豐膠囊工業股份有限公司 解支酶改質澱粉，其製備方法及其於硬空膠囊製造上的應用
US11540549B2 (en) 2019-11-28 2023-01-03 Tate & Lyle Solutions Usa Llc High-fiber, low-sugar soluble dietary fibers, products including them and methods for using them
US12133918B2 (en) * 2021-10-01 2024-11-05 Griffin Gamma, Llc Partially pre-gelatinized cassava starch as pharmaceutical excipient
CN115356291A (zh) * 2022-09-13 2022-11-18 安徽皖维高新材料股份有限公司 一种采用阿贝折射仪快速测定四水合酒石酸钾钠纯度的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3730840A (en) * 1968-04-01 1973-05-01 Hayashibara Co Process for preparing low molecular weight amyloses
US3881991A (en) * 1969-01-24 1975-05-06 Hayashibara Co Process for producing amylose powders having a mean degree of polymerization between 20{14 30
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4384005A (en) * 1980-09-26 1983-05-17 General Foods Corporation Non-friable, readily-soluble, compressed tablets and process for preparing same
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
US5089171A (en) * 1988-10-14 1992-02-18 National Starch And Chemical Investment Holding Corporation Partially debranched starch clouds
US5194284A (en) * 1988-10-14 1993-03-16 National Starch And Chemical Investment Holding Corporation Foods opacified with debranched starch
US4971723A (en) * 1988-10-14 1990-11-20 National Starch And Chemical Investment Holding Corporation Partially debranched starches and enzymatic process for preparing the starches
US5468286A (en) * 1989-10-25 1995-11-21 National Starch And Chemical Investment Holding Corporation Enzymatically debranched starches as tablet excipients
US5051271A (en) * 1989-11-22 1991-09-24 Opta Food Ingredients, Inc. Starch-derived, food-grade, insoluble bulking agent
US5409726A (en) * 1990-02-20 1995-04-25 A. E. Staley Manufacturing Co. Method of preparing reduced fat foods
US5387426A (en) * 1990-02-20 1995-02-07 A.E. Staley Manufacturing Company Method of preparing reduced fat foods
CA2032385A1 (en) * 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients
JPH0749378B2 (ja) * 1990-12-27 1995-05-31 ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション タブレット賦形剤としての酵素的に枝切りされたデンプン
FI111088B (fi) * 1994-04-15 2003-05-30 Cerestar Holding Bv Menetelmä tärkkelyspitoisten tuotteiden valmistamiseksi
NL1003747C2 (nl) * 1996-08-06 1998-02-12 Avebe Coop Verkoop Prod Amyloseproducten als matrixvormer voor geprogrammeerde afgiftesystemen, werkwijze voor het bereiden van deze amyloseproducten alsmede werkwijze voor het maken van geprogrammeerde afgiftesystemen.
CA2211778A1 (en) * 1997-08-14 1999-02-14 Francois Carriere Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
DE19911001C2 (de) * 1999-03-12 2002-06-20 Aventis Cropscience Gmbh Verfahren zur Herstellung resistenter Stärke, resistente Stärke und deren Verwendung

Also Published As

Publication number Publication date
EP1503738A1 (en) 2005-02-09
US20030215499A1 (en) 2003-11-20
JP2005530777A (ja) 2005-10-13
WO2003097017A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
GB0218625D0 (en) Pharmaceutical compounds
AU2003291103A1 (en) Pharmaceutical composition
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
GB0217225D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003250372A1 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
AU2003234416A1 (en) Use of completely linear short chain alpha-glucans as a pharmaceutical excipient
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003284460A1 (en) Medicinal composition
AU2003208621A1 (en) A pharmaceutical composition
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents
AU2003255727A1 (en) Syringes
AU2003280799A1 (en) Medicinal composition
GB0204392D0 (en) Pharmaceutical compound
AU2003280678A1 (en) Medicinal composition
AU2003222571A1 (en) Novel therapeutic application for a composition
AUPS188302A0 (en) Pharmaceutical composition
AU2003207055A1 (en) Novel drugs for external use
GB0213639D0 (en) Pharmaceutical excipient
AU2002950182A0 (en) Compounds for medicinal purposes
AU2003238900A1 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase